HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.
A T-cell subset, defined as CD4(+)CD25(hi) (regulatory T-cells [Treg cells]), was recently shown to suppress T-cell activation. We demonstrate that human Treg cells isolated from healthy donors express the HIV-coreceptor CCR5 and are highly susceptible to HIV infection and replication. Because Treg cells are present in very few numbers and are difficult to expand in vitro, we genetically modified conventional human T-cells to generate Treg cells in vitro by ectopic expression of FoxP3, a transcription factor associated with reprogramming T-cells into a Treg subset. Overexpression of FoxP3 in naïve human CD4(+) T-cells recapitulated the hyporesponsiveness and suppressive function of naturally occurring Treg cells. However, FoxP3 was less efficient in reprogramming memory T-cell subset into regulatory cells. In addition, FoxP3-transduced T-cells also became more susceptible to HIV infection. Remarkably, a portion of HIV-positive individuals with a low percentage of CD4(+) and higher levels of activated T-cells have greatly reduced levels of FoxP3(+)CD4(+)CD25(hi) T-cells, suggesting disruption of the Treg cells during HIV infection. Targeting and disruption of the T-cell regulatory system by HIV may contribute to hyperactivation of conventional T-cells, a characteristic of HIV disease progression. Moreover, the ability to reprogram human T-cells into Treg cells in vitro will greatly aid in decoding their mechanism of suppression, their enhanced susceptibility to HIV infection, and the unique markers expressed by this subset.
Oswald-Richter
Kyra
K
Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, Tennessee, USA.
Grill
Stacy M
SM
Shariat
Nikki
N
Leelawong
Mindy
M
Sundrud
Mark S
MS
Haas
David W
DW
Unutmaz
Derya
D
D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D002460:Cell Line; D049109:Cell Proliferation; D002469:Cell Separation; D002472:Cell Transformation, Viral; D003001:Cloning, Molecular; D016207:Cytokines / Q000378:metabolism; D018450:Disease Progression; D005434:Flow Cytometry; D051858:Forkhead Transcription Factors / Q000378:metabolism; D005818:Genetic Engineering; D015658:HIV Infections / Q000473:pathology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D008969:Molecular Sequence Data; D010641:Phenotype; D019713:Receptors, CCR5 / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism / Q000821:virology*
D016207:Cytokines; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D019713:Receptors, CCR5; D015375:Receptors, Interleukin-2